Nationwide Pharmacy Law Updates
The purpose of this page is to offer a concise overview of recent developments in pharmacy law across the United States. While this serves as a helpful starting point for understanding these changes, please note that it is not an exhaustive reference. Detailed information and specific restrictions can vary; therefore, we strongly recommend consulting the respective state Boards of Pharmacy for full and accurate details.
2024 Updates - Current through October 2024
Louisiana
May 2024: Marijuana Pharmacy Rule Amendments: Louisiana is easing marijuana pharmacy regulations, reducing producer testing, packaging, and expanding the number of active marijuana pharmacy permits.
Kentucky
May 2024: Hazardous Drugs and Compounding Definitions: Kentucky added definitions related to hazardous drugs and “essential copies” of commercially available products to its compounding regulations to align with USP standards.
New Mexico
May 2024: Ketamine Joint Advisory: A joint advisory from New Mexico’s pharmacy, nursing, and medical boards warns against the off-label use of ketamine, emphasizing patient education and mandatory reporting.
California
May 2024: Medication Error Reporting Law: New legislation mandates all licensed community pharmacies to report medication errors and provides allowances for increased staffing to prevent fatigue and ensure patient safety.
Michigan
June 2024: Removal of MPJE Requirement: Michigan eliminated the Multistate Pharmacy Jurisprudence Exam (MPJE) requirement for licensure, which was controversial due to concerns about pharmacists' knowledge of state-specific laws.
Florida
June 2024: Drug Importation Program: Florida's Section 804 Drug Importation Program received FDA approval, outlining a system for importing prescription medications from Canada with robust safety and inspection measures.
Oregon
October 2024: New Bills on OUD Medications and Flavoring: Oregon passed bills concerning the dispensing of opioid use disorder (OUD) medications and the flavoring of prescription drugs to improve patient compliance and safety
Ohio
January 2024: The Ohio Board of Pharmacy implemented a COVID-19 operational waiver allowing pharmacy technician trainees to stock automated pharmacy systems under certain conditions. Certified and registered pharmacy technicians have specific guidelines for stocking automated drug storage systems.
February 2024: Ohio has initiated a program to distribute free fentanyl test strips to pharmacies throughout the state. This effort, tied to Overdose Awareness Day, aims to equip pharmacies with tools to help prevent overdoses, with each licensed pharmacy eligible to receive up to two boxes of test strips.
South Carolina
January 2024: The South Carolina General Assembly enacted a law that protects the identities of pharmacy staff involved in executing death sentences, allowing pharmacies and pharmacists to dispense directly to the South Carolina Department of Corrections without a prescription.
Alabama
January 2024: Alabama has amended its laws to expand the practitioner workforce by allowing pharmacists to provide remote pharmacy services, enhancing patient care access and safety.
March 2024: Permanent rules now allow Alabama pharmacists to perform certain tasks outside of a permitted pharmacy/ facility in certain primary care models.
Massachusetts
January 2024: Massachusetts has updated its pharmacy practice requirements and COVID-19 control measures, adapting to the end of the public health emergency and ongoing staffing challenges.
Oregon
January 2024: Oregon passed several bills affecting pharmacy technicians and drug outlets, including the adoption of temporary licenses for pharmacy technicians and revisions in the definitions for nonprescription drug outlets and wholesale distributors.
Washington
February 2024: Washington State is proposing new regulations to establish minimum standards for remote dispensing sites for Opioid Use Disorder (OUD) medications. This initiative, driven by Substitute Senate Bill 6086, aims to enhance access to medications essential for treating OUD.
May 2024: Rulemaking Inquiry Regarding Transfer Practices: Washington is considering rules for "white bagging" and "brown bagging" practices, aimed at regulating the transfer of dispensed prescription drugs to protect patient safety.
Iowa
February 2024: Iowa has updated its statewide protocol allowing pharmacists to distribute any FDA-approved opioid antagonist for overdose reversal to eligible recipients aged 18 and older. This update expands the scope of pharmacists' ability to provide critical care.
North Dakota
February 2024: North Dakota is proposing changes to its pharmacy regulations to broaden the use of the term "opioid antagonist" instead of "naloxone," enabling pharmacists to prescribe a wider range of medications within this category.
Oregon
February 2024: Oregon has made several amendments to its pharmacy regulations concerning short-acting opioid antagonists. The amendments include updating terms and integrating labeling exemptions for nasal sprays dispensed by prescribers, aiming to streamline the processes in pharmacies, correctional facilities, and health clinics.
Tennessee
March 2024: Legislation passed adding two additional seats to the Tennessee Board of Pharmacy, including a pharmacist and a pharmacy technician.
West Virginia
March 2024: New emergency rules regarding prescription processing and governing pharmacy permits have been approved, including Regulation 15-1-5 regarding centralized prescription processing.
North Carolina
March 2024: Authorization for the use of direct-to-patient (DTP) dispensing systems in certain circumstances was completed by the North Carolina Board of Pharmacy.
June 2024: Rule Changes for Licensure Processes: North Dakota updated its licensure requirements, streamlining processes and making changes aimed at improving efficiency in pharmacist licensure.
Texas
March 2024: The Texas State Board of Pharmacy adopted and proposed several amendments to its rules during its November Board Meeting, impacting the military service members and outlining procedures for licensing and registration.
2023 Updates
Alabama
January 2023: Amended the 680-X-2-.18 Institutional Pharmacies rule to help patients obtain emergency dispensing medications upon discharge. These medications must include specific labeling details for proper storage, handling, safety, and usage.
February 2023: Amended the Role of Technicians in Pharmacies rule, specifying sufficient ratios of technicians per full-time licensed pharmacist, including certification requirements for technicians by a Board-approved credentialing organization.
California
March 2023: Clarified regulations on "inventory reconciliation" and defined "inventory activities." The amendment specifies inventory requirements for controlled substances and establishes procedures for inventory documentation and reporting.
October 2023: Amended regulation clarifying "inventory reconciliation" and "inventory activities," specifying when controlled substances must be inventoried and requirements for documenting and reporting inventories.
District of Columbia
October 2023: Introduced LinkU DMV, a resource for finding free and reduced-cost services for patients in the DC/Maryland/Virginia area, including a community needs assessment to help residents find medical care, food, housing, etc.
Idaho
October 2023: Passed House Bill (HB) 162 during the 2023 legislative session. This legislation expands the ability of Idaho citizens in rural and underserved areas to access health care from providers not physically present in the patient's geographical area. The bill updates the Idaho Telehealth Access Care Act by changing "telehealth" to "virtual care" and clarifying virtual care practice requirements.
Iowa
January 2023: Implemented new rules allowing veterinarians to dispense from office stock in limited circumstances. The product can be dispensed from office stock to the owner of a veterinary patient to treat an immediate medical need when timely access to a patient-specific supply of compounded medication is not available.
October 2023: Amended rules in multiple chapters to implement changes made to the Iowa Code during the 2022 legislative session. This includes authorizing registered nurses to assist in the administration of immunizations and vaccinations pursuant to a pharmacist's order.
Louisiana
October 2023: Provided updates on the Louisiana Board of Pharmacy's regulatory and legislative activities on its website, including reviews of regulatory proposals on DATA-Waiver registration elimination, health care workplace violence prevention, marijuana pharmacy, pharmacy benefits managers, and more.
Massachusetts
February 2023: Passed Chapter 127 of the Acts of 2022, establishing a statewide standing order for all retail pharmacies to use for dispensing emergency contraception. Training program available through the MGH Institute of Health Professions, also offering continuing education credits.
Maryland
September 2023: Expanded the membership of the Maryland Board of Pharmacy to include a registered pharmacy technician. Authorized remote prescription-related data entry and granted administration authority of certain vaccines to registered pharmacy technicians.
Mississippi
April 2023: No longer grants a temporary "pending" status to technicians who have successfully submitted all application components except background check results. Technicians must reflect "active" on the licensing verification portal to be allowed in the dispensing area of a pharmacy.
New Jersey
July/August 2023: Approved a pilot program pursuant to New Jersey Statutes Annotated 45:14-48(b)(10), allowing for the dispensing of opioid antidotes at no cost to anonymous recipients at pharmacies with standing orders from the commissioner of health or a New Jersey-licensed physician.
New Mexico
January 2023: Approved rule updates including amendments to the New Mexico Administrative Code related to pharmacist definitions and controlled substances management.
October 2023: Amended the practice of pharmacy definition in SB 92 to include prescribing devices or supplies for prescribed drug therapy for health conditions and ordering, performing, and interpreting FDA-approved tests.
North Carolina
January 2023: Revived a requirement for pharmacists to notify prescribers when dispensing an interchangeable biosimilar product. This notification must occur within five business days and include the product name and manufacturer.
Ohio
February 2023: Amended Ohio Administrative Code to require pharmacists to check the Ohio Automated Rx Reporting System (OARRS) report before dispensing medications containing gabapentin, addressing overutilization concerns.
Oregon
February 2023: Adopted permanent rules requiring Retail Drug Outlet pharmacies to notify the public of temporary, emergency, and permanent pharmacy closures, with specific guidelines for notification procedures.
South Carolina
May 2023: Finalized the joint protocol for the Pharmacy Access Act. Act 210 allows pharmacists to dispense a self-administered hormonal contraceptive or administer an injectable hormonal contraceptive pursuant to a standing order by a prescriber.
South Dakota
April 2023: The South Dakota Interim Rules Review Committee certified that Administrative Rules of South Dakota 20:51:35 could move forward to final form. The rules elaborate on criteria for pharmacies to accept donated prescription drugs.
Tennessee
March 2023: Passed two legislative initiatives related to local county health departments and the Controlled Substance Monitoring Database. Required the Board to review rules Public Chapter (PC) 812, PC 908, and PC 1010, which impact pharmacy technicians' scope of practice and collaborative practice agreements for dispensing ivermectin.
Texas
March 2023: Implemented a new statutory requirement for Board-licensed pharmacists registered before June 1, 2015, to undergo an additional fingerprint background check before renewing their Board license.
Utah
February 2023: Passed the Cybersecurity Affirmative Defense Act, providing protection to businesses that create, maintain, and comply with industry-recognized cybersecurity regulations.
Washington
January 2023: Filed a rulemaking inquiry to consider adding or amending rules related to prescription label accessibility standards.
October 2023: Filed a rulemaking inquiry under WSR 22-09-065 to consider adding or amending rules in Chapter 246-945 Washington Administrative Code, focusing on prescription label accessibility standards.
Wyoming
October 2023: Reminded pharmacies of the need to obtain a license to dispense antimicrobials pursuant to a prescription following FDA's guidance changes.
————————————————
2022 updates
e-prescribing - as of January 2022
9 states require e-prescribing for all prescriptions: CA, FL, IA, MI, MN, NV, NY, PA, WV
Other states have regulations related to e-prescribing specific to controlled substances
Further restrictions apply; check BOP for state-specific details
DEA
DEA allows practitioners in various settings to dispense a 3-day supply of MAT. Prerequisite: Practitioners should request an exception from the DEA before performing this action
2022 - New Mexico
Board-approved prescriptive authority for pharmacists to prescribe prophylaxis therapy in conjunction with point-of-care testing. Certain training is required. Check BOP for details
Technicians are allowed to administer vaccines. Training and supervision requirements apply. The pharmacist is ultimately responsible. See BOP law for full details
2022 - Wyoming
A new 2-phase sterile compounding inspection process is now implemented
2022 - Missouri
Prescription transfer requests (initiated by patient or caregiver) must be completed within one business day
2022 - Washington state
Healthcare professionals performing telehealth services must complete specific training before rendering these services
2022 - District of Columbia
New labeling requirements: prescription opioid drugs must include a statement added on the container indicating that the drug is an opioid and has a risk of overdose and addiction
2022 - Massachusetts
pharmacies can fill CII from non-resident practitioners who have prescription authority from another state.
Reminders regarding CII:
CII prescriptions from out of state are valid for 5 days from the date they were issued
CII non-narcotic prescriptions can be filled from any state
CII narcotic prescriptions can be filled from states contiguous to Massachusetts or from Maine
2022 - Louisiana
BOP updated several chapters impacting pharmacy administration, pharmacy operation, tele-pharmacy, among other updates. See BOP website for complete details
2022 - Nevada
Pharmacists are allowed to dispense self-administered hormonal contraceptives to patients under protocol byt= the Nevada State BOP without a prescription. Restrictions and limitations apply.
All controlled substance prescriptions must be sent via e-prescribing software
2022 - Tennessee
BOP requires additional data points to be populated (by pharmacist/prescriber) in the Controlled Substances Monitoring Database.
BOP added additional rules outlining the usage of CSMD during the dispensing of CII amphetamines
_____________________________
2021
2021 - Federal
DEA Form 222 is a single-sheet form only. The triplicate form/usage had a sunset date of October 2021
2021 - Georgia
Effective July 2021: HB316 amended the pharmacist-to-technician ratio. The new ratio is 1:4, previously 1:3. Bill includes other updates related to the professional judgment and responsibilities of a pharmacist.
2021 - Massachusetts
Updates to the scope of practice for pharmacists, technicians, and interns regarding the administration of vaccines and medication specific for mental illness/ substance use disorder. Additionally, allowing technicians to perform remote prescription processing and perpetual inventory (restrictions apply, see BOP rules of details). Reference: here
2021 - Ohio
LTC entities are allowed to store and administer vaccinations and biologics to staff members and patients using the entity’s specific dangerous drugs terminal distributor license. (restrictions apply, see BOP rules for details). Reference: here
2021 - Oregon
Approved House and Senate bills that can impact the profession of pharmacy effective 2022
Senate Bill 629: Allowing pharmacists to use telepharmacy to perform specific services
House Bill 2648: Allowing pharmacists/technicians to transfer pseudoephedrine containing drugs (restrictions apply)
House Bill 2958: Allows pharmacists to prescribe, dispense, and administer pre/post-exposure prophylactic antiretroviral drugs (restrictions apply)
2021 - West Virginia
West Virginia pharmacists must check the West Virginia Controlled Substance Monitoring Program database when handling prescriptions for specific populations: CII, Opioids, and Benzodiazepine (restrictions apply, see BOP for details)
2021 - Minnesota
Product labels: Products containing cannabinoids extracted from hemp can have QR code (or other scannable technology) that link directly to the manufacturer’s website
RountableRX accepts the donation of certain PTC products (restrictions apply)
2021 - California
January 2022: Specific rules related to the transmission and receiving of prescriptions electronically (restrictions apply, see BOP for details). Reference: here
2021 - Iowa
Pharmacists must review patient’s medication history prior to dispensing any CV medication that does not require a prescription
Updated PMP requirements:
CV should be reported to the PMP
Cough suppressants with codeine should be reported to the PMP
2021 - North Dakota
Pharmacists can administer vaccines and injectables to patients 3+ years old (restrictions apply)
Pharmacists can dispense emergency fills for up to 30 day supply (previously 72 hours)
2021 - North Carolina
Epidiolex® is now an unscheduled drug both Federally and in North Carolina (previously was CV)
2021 - Virginia
Emergency regulations authorizing pharmacists to initiate treatment with certain drugs for patients 18 years of age or older became effective January 3, 2021. Pharmacists may now prescribe and dispense these drugs in accordance with the regulations and the statewide protocols listed below (reference: here):
Hormonal contraception, emergency contraception
Prenatal vitamins
Naloxone
Epinephrine
Lowering out-of-pocket expenses
Dietary Fluoride supplement